SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600132-16-000066
Filing Date
2016-05-18
Accepted
2016-05-18 13:46:32
Documents
1
Period of Report
2016-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146359357872805.html 4  
1 FORM 4 wf-form4_146359357872805.xml 4 3584
  Complete submission text file 0001600132-16-000066.txt   5017
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Peacock Jonathan M (Reporting) CIK: 0001500241 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 161660104

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations